Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Transplantation in 2011

New agents, new ideas and new hope

Nature Reviews Nephrology volume 8, pages 74–75 (2012)Cite this article

Subjects

The past year was marked by several excellent studies that represent important therapeutic advances in kidney transplantation or that further our understanding of the genetic basis of chronic allograft dysfunction, clinical tolerance and outcomes of kidney transplantation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Larsen, C. P. et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transplant. 5, 443–453 (2005).

    Article  CAS  Google Scholar 

  2. Vincenti, F. et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am. J. Transplant. 10, 535–546 (2010).

    Article  CAS  Google Scholar 

  3. Vincenti, F. et al. Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am. J. Transplant. http://dx.doi.org/10.1111/j.1600–6143.2011.03785.x.

  4. Montgomery, R. A. et al. Desensitization in HLA-incompatible kidney recipients and survival. N. Engl. J. Med. 365, 318–326 (2011).

    Article  CAS  Google Scholar 

  5. Friedman, D. J., Kozlitina, J., Genovese, G., Jog, P. & Pollak, M. R. Population-based risk assessment of APOL1 on renal disease. J. Am. Soc. Nephrol. 22, 2098–2105 (2011).

    Article  CAS  Google Scholar 

  6. Reeves-Daniel, A. M. et al. The APOL1 gene and allograft survival after kidney transplantation. Am. J. Transplant. 11, 1025–1030 (2011).

    Article  CAS  Google Scholar 

  7. Newell, K. A. et al. for the Immune Tolerance Network ST507 Study Group. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120, 1836–1847 (2010).

    Article  CAS  Google Scholar 

  8. Lozano, J. J. et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am. J. Transplant. 11, 1916–1926 (2011).

    Article  CAS  Google Scholar 

  9. Merion, R. M. et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294, 2726–2733 (2005).

    Article  CAS  Google Scholar 

  10. Kayler, L. K., Srinivas, T. R. & Schold, J. D. Influence of CIT-induced DGF on kidney transplant outcomes. Am. J. Transplant. 11, 2657–2664 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, 9500 Euclid Avenue, Cleveland, 44195, OH, USA

    Titte R. Srinivas

  2. Division of Nephrology, University of Arizona School of Medicine, 1501 North Campbell Avenue, Tucson, 85724, AZ, USA

    Bruce Kaplan

Authors
  1. Titte R. Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce Kaplan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srinivas, T., Kaplan, B. New agents, new ideas and new hope. Nat Rev Nephrol 8, 74–75 (2012). https://doi.org/10.1038/nrneph.2011.215

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2011.215

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing